Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor regulatory T cells for visceral acute GVHD
NCT02526329Phase 1Withdrawn
- Start
- Aug 2015
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial of donor regulatory T lymphocytes in Acute Graft-Versus-Host Disease (aGVHD). Primary endpoint: Incidence of grade 3 infusion reaction at 24 hours. Planned start Aug 2015; status: withdrawn.
02
Drugs
donor regulatory T lymphocytes
03
Conditions
Acute Graft-Versus-Host Disease (aGVHD)
Beyond the preview
Go deeper on NCT02526329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526329.